Clinical trial
Assess the Safety and Efficacy of Lepu® Drug Coated Balloon Versus RESTORE® Paclitaxel Eluting Balloon for the Treatment of Coronary Small-vessel Disease: a Prospective, Multicenter, Randomized, Controlled Trial
NCT04953117 is registered in ClinicalTrials.gov with Lepu Medical Technology (Beijing) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assess the Safety and Efficacy of Lepu® Drug Coated Balloon Versus RESTORE® Paclitaxel Eluting Balloon for the Treatment of Coronary Small-vessel Disease: a Prospective, Multicenter, Randomized, Controlled Trial
- Lead sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 10, 2021
- Completion date
- April 30, 2023
- Enrollment
- 286 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.